Literature DB >> 3367635

Basis of neurovirulence in Sindbis virus encephalomyelitis of mice.

A C Jackson1, T R Moench, B D Trapp, D E Griffin.   

Abstract

Neuroadapted Sindbis virus (NSV) was selected by serial passage of wild-type Sindbis virus (SV) in mouse brain. After intracerebral inoculation of weanling mice, NSV causes a severe encephalomyelitis with hindlimb paralysis and high mortality; SV causes nonfatal mild disease. In order to determine the biologic basis of neurovirulence in vivo, these viral infections have been compared by using infectivity assays, light and electron microscopy, in situ hybridization, immunohistochemistry, and double-labeling for neural cell markers and viral RNA. More infectious virus is present in the central nervous system during NSV than during SV infection. After intracerebral inoculation, both viruses enter the central nervous system via the ependyma and spread to gray matter areas, including the ventral horns of the spinal cord. Their cellular targets are not different, and neuronal infection is prominent. NSV infects more neurons, and causes more severe injury than SV. In NSV infection, there is marked swelling of lumbar and thoracic neurons and their processes in the ventral horns. Relatively mild changes are detected in SV infection only by electron microscopy. Neuroadaptation likely occurs by increasing the efficiency of viral replication in neurons, rather than by a fundamental change in the cellular tropism or the topography of the infection in the central nervous system.

Entities:  

Mesh:

Year:  1988        PMID: 3367635

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  67 in total

1.  Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis.

Authors:  Kirsten A Kulcsar; Victoria K Baxter; Ivorlyne P Greene; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-31       Impact factor: 11.205

2.  Adaptive changes in alphavirus mRNA translation allowed colonization of vertebrate hosts.

Authors:  Iván Ventoso
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

3.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

4.  NF-κB Activation Promotes Alphavirus Replication in Mature Neurons.

Authors:  Jane X Yeh; Eunhye Park; Kimberly L W Schultz; Diane E Griffin
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

5.  BCL-2 and BAX protect adult mice from lethal Sindbis virus infection but do not protect spinal cord motor neurons or prevent paralysis.

Authors:  Douglas A Kerr; Thomas Larsen; Susan H Cook; Yih-Ru Fannjiang; Eunkyung Choi; Diane E Griffin; J Marie Hardwick; David N Irani
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 6.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

7.  Effects of anti-E2 monoclonal antibody on sindbis virus replication in AT3 cells expressing bcl-2.

Authors:  P Després; J W Griffin; D E Griffin
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis.

Authors:  P C Tucker; D E Griffin; S Choi; N Bui; S Wesselingh
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype.

Authors:  Steven A Rubin; Georgios Amexis; Mikhail Pletnikov; Zongqi Li; Jacqueline Vanderzanden; Jeremy Mauldin; Christian Sauder; Tahir Malik; Konstantin Chumakov; Kathryn M Carbone
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Neurovirulent strains of Alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoprotein.

Authors:  S Ubol; P C Tucker; D E Griffin; J M Hardwick
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.